Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects.
暂无分享,去创建一个
L. Kuller | B. Psaty | M. Cushman | R. Tracy | E. Bovill | E. Cornell | E. Macy | Elaine S. Cornell | B. Psaty
[1] L H Kuller,et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[2] R. Tracy,et al. Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. , 1997, Clinical chemistry.
[3] L. Kuller,et al. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial. , 1996, American journal of epidemiology.
[4] L. Kuller,et al. Correlates of thrombin markers in an elderly cohort free of clinical cardiovascular disease. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[5] J. Harvey-Berino,et al. Amelioration of the inhibition of fibrinolysis in elderly, obese subjects by moderate energy intake restriction. , 1996, The American journal of clinical nutrition.
[6] P. Savage,et al. Association of Fibrinogen and Coagulation Factors Vll and VIII with Cardiovascular Risk Factors in the Elderly The Cardiovascular Health Study , 1996 .
[7] C. Alpers,et al. Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. , 1996, Circulation.
[8] T. Ueno,et al. Increased soluble form of P-selectin in patients with unstable angina. , 1995, Circulation.
[9] P. Savage,et al. Fibrinogen and factor VIII, but not factor VII, are associated with measures of subclinical cardiovascular disease in the elderly. Results from The Cardiovascular Health Study. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[10] P. Savage,et al. Coronary heart disease prevalence and its relation to risk factors in American Indians. The Strong Heart Study. , 1995, American journal of epidemiology.
[11] A. Blann,et al. von Willebrand Factor, Soluble P-Selectin, Tissue Plasminogen Activator and Plasminogen Activator Inhibitor in Atherosclerosis , 1995, Thrombosis and Haemostasis.
[12] S. Thompson,et al. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. , 1995, The New England journal of medicine.
[13] M. Cushman,et al. Laboratory methods and quality assurance in the Cardiovascular Health Study. , 1995, Clinical chemistry.
[14] R. Tracy,et al. The measurement of fibrinogen in population-based research. Studies on instrumentation and methodology. , 1994, Archives of pathology & laboratory medicine.
[15] A. Rebuzzi,et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. , 1994, The New England journal of medicine.
[16] A. Blann,et al. Circulating Endothelial Cell/Leukocyte Adhesion Molecules in Atherosclerosis , 1994, Thrombosis and Haemostasis.
[17] J. Gardin,et al. Prevalence of subclinical atherosclerosis and cardiovascular disease and association with risk factors in the Cardiovascular Health Study. , 1994, American journal of epidemiology.
[18] V. Fuster,et al. Atherogenesis and inflammation. , 1993, European heart journal.
[19] J. Polak,et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. , 1993, Circulation.
[20] M. Entman,et al. Inflammation in Acute Coronary Syndromes , 1993, Circulation.
[21] G. Vercellotti,et al. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor , 1993 .
[22] L. Fried,et al. Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study. , 1993, Annals of epidemiology.
[23] C. Fraser,et al. Biological Variation of Acute Phase Proteins , 1993, Annals of clinical biochemistry.
[24] E. Meilahn,et al. Sample preparation for plasma measurement of plasminogen activator inhibitor-1 antigen in large population studies. , 1993, Archives of pathology & laboratory medicine.
[25] B. Klein,et al. C-reactive protein levels as a direct indicator of interleukin-6 levels in humans in vivo. , 1992, Arthritis and rheumatism.
[26] B. Psaty,et al. Major electrocardiographic abnormalities in persons aged 65 years and older (the Cardiovascular Health Study). Cardiovascular Health Study Collaborative Research Group. , 1992, The American journal of cardiology.
[27] H. S. Klopfenstein,et al. Echocardiographic design of a multicenter investigation of free-living elderly subjects: the Cardiovascular Health Study. , 1992, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[28] K. Mann,et al. Studies on the measurement of protein S in plasma. , 1991, Clinical chemistry.
[29] B M Psaty,et al. Use of sonography to evaluate carotid atherosclerosis in the elderly. The Cardiovascular Health Study. CHS Collaborative Research Group. , 1991, Stroke.
[30] M. Nyska,et al. Acute Phase Protein, Serum Amyloid A, Inhibits IL‐1‐ and TNF‐Induced Fever and Hypothalamic PGE2 in Mice , 1991, Scandinavian journal of immunology.
[31] G. Fuller,et al. The putative role of fibrin fragments in the biosynthesis of fibrinogen by hepatoma cells. , 1991, Biochemical and biophysical research communications.
[32] R. Kronmal,et al. The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.
[33] P. Declerck,et al. Correlations between t-PA and PAI-1 antigen and activity and t-PA/PAI-1 complexes in plasma of control subjects and of patients with increased t-PA or PAI-1 levels. , 1990, Thrombosis research.
[34] A. Marcus,et al. Stratton lecture 1989. Thrombosis and inflammation as multicellular processes: pathophysiologic significance of transcellular metabolism. , 1990, Blood.
[35] N. Ku,et al. Regulation of cytokine-induced human C-reactive protein production by transforming growth factor-beta. , 1990, Journal of immunology.
[36] K. Mann,et al. Fibrin fragment D-dimer and fibrinogen B beta peptides in plasma as markers of clot lysis during thrombolytic therapy in acute myocardial infarction. , 1990, Blood.
[37] I. Kushner,et al. C-reactive protein and the acute-phase response. , 1990, Hospital practice.
[38] P. Hass,et al. A monoclonal-antibody-based enzyme-linked immunosorbent assay of lipoprotein(a). , 1990, Clinical chemistry.
[39] P. Declerck,et al. Measurement of different forms of plasminogen activator inhibitor 1(PAI-1) using various monoclonal antibody-based enzyme-linked immunosorbent assays , 1990 .
[40] R. Macwalter,et al. Biological variability of 26 clinical chemistry analytes in elderly people. , 1989, Clinical chemistry.
[41] S. Deodhar,et al. C-reactive protein: the best laboratory indicator available for monitoring disease activity. , 1989, Cleveland Clinic journal of medicine.
[42] C G Fraser,et al. Generation and application of data on biological variation in clinical chemistry. , 1989, Critical reviews in clinical laboratory sciences.
[43] K. Mann,et al. A monoclonal-antibody-based radioimmunoassay for measurement of protein C in plasma. , 1988, Clinical chemistry.
[44] R. Cotran,et al. The pathogenesis of atherosclerosis: atherogenesis and inflammation. , 1988, Laboratory investigation; a journal of technical methods and pathology.
[45] M. Alessi,et al. Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. , 1988, Blood.
[46] P. Holvoet,et al. An Enzyme-Linked Immunosorbent Assay (ELISA) for the Measurement of Plasmin-α2-Antiplasmin Complex in Human Plasma - Application to the Detection of In Vivo Activation of the Fibrinolytic System , 1986, Thrombosis and Haemostasis.
[47] I. Das,et al. Raised C-reactive protein levels in serum from smokers. , 1985, Clinica chimica acta; international journal of clinical chemistry.
[48] D. Collen,et al. Assay of Human Tissue-Type Plasminogen Activator (t-PA) with an Enzyme-Linked Immunosorbent Assay (ELISA) Based on Three Murine Monoclonal Antibodies to t-PA , 1985, Thrombosis and Haemostasis.
[49] A. J. Valente,et al. Atherosclerosis as an Inflammatory Process , 1985, Annals of the New York Academy of Sciences.
[50] N. Tietz. Clinical guide to laboratory tests , 1983 .
[51] I. Kushner,et al. SERUM C‐REACTIVE PROTEIN LEVELS IN DISEASE * , 1982, Annals of the New York Academy of Sciences.
[52] D. Ritchie,et al. Regulation of fibrinogen synthesis by plasmin-derived fragments of fibrinogen and fibrin: an indirect feedback pathway. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[53] C. Mold,et al. C-reactive protein and the acute phase response. , 1982, Advances in internal medicine.
[54] D. Karp,et al. Control of the acute phase response. Serum C-reactive protein kinetics after acute myocardial infarction. , 1978, The Journal of clinical investigation.
[55] E. Simonson,et al. The Electrocardiogram in Population Studies: A Classification System , 1960, Circulation.